| |
Tumor-free SLNs (n = 25)
|
Tumor-containing SLNs (n = 25)
|
|---|
|
Patient age (years)
| | |
|
Median
|
56
|
55
|
|
Range
|
35–76
|
26–87
|
|
Tumor size (cm)
| | |
|
Median
|
1.4
|
1.5
|
|
Range
|
0.1–5
|
0.6–4.5
|
|
Steroid receptor status
| | |
|
Estrogen receptor-positive
|
17 (68%)a
|
19 (76%)
|
|
Estrogen receptor-negative
|
4 (16%)
|
6 (24%)
|
|
Unknown
|
4 (16%)
|
0
|
|
Progesterone receptor-positive
|
15 (60%)
|
18 (72%)
|
|
Progesterone receptor-negative
|
5 (20%)
|
7 (28%)
|
|
Unknown
|
5 (20%)
|
0
|
|
Tumor grade
| | |
|
Grade I
|
3 (12%)
|
3 (12%)
|
|
Grade II
|
11 (44%)
|
12 (48%)
|
|
Grade III
|
8 (32%)
|
8 (32%)
|
|
Unknown
|
3 (12%)
|
2 (8%)
|
-
a Data presented as number (percentage of total number of SLNs in each category).
